PHARMAC - Latest News [Page 24]
Brand change for ADHD medication
Friday, 29 September 2006, 3:57 pm | PHARMAC
New Zealanders taking long-acting methylphenidate – mostly children with the behavioural condition Attention Deficit Hyperactivity Disorder (ADHD) – will see a change in the brand of their medication from 1 November. More >>
PHARMAC to fund medicine for acute heart patients
Thursday, 28 September 2006, 3:08 pm | PHARMAC
From 1 October 2006, people with acute heart problems will benefit from a decision by PHARMAC to subsidise clopidogrel, a drug that helps prevent blood clots developing in arteries. More >>
Breast cancer treatments get a funding boost
Thursday, 31 August 2006, 3:43 pm | PHARMAC
Treatments for early breast cancer are getting a boost with a decision to fund the taxane drug paclitaxel for early breast cancer. More >>
New weapon for battle against HIV/AIDS
Thursday, 24 August 2006, 4:06 pm | PHARMAC
The first of a new type of drugs to treat HIV/AIDS will be funded for New Zealanders from next month. More >>
Further Herceptin information received by PTAC
Thursday, 17 August 2006, 4:39 pm | PHARMAC
PHARMAC’s clinical advisory committee PTAC today considered further information on the use of Herceptin for early breast cancer. More >>
PHARMAC: Herceptin - Questions and answers
Friday, 28 July 2006, 3:50 pm | PHARMAC
Why is Herceptin not yet funded in NZ? The evidence on Herceptin is not yet strong enough to enable PHARMAC to make a positive funding decision on Herceptin. PHARMAC remains open to funding the drug and will be continuously reviewing further evidence ... More >>
Herceptin not funded, under continuing review
Friday, 28 July 2006, 1:41 pm | PHARMAC
Funding has not yet been approved for breast cancer drug Herceptin, but will be kept under review by Government drug-funding agency PHARMAC as new information emerges. More >>
Asthma inhaler range gets a positive shake-up
Wednesday, 26 July 2006, 11:09 am | PHARMAC
Subsidies for asthma inhalers will get a big shake-up from 1 August. More people will be able to have long-acting inhalers, such as Oxis and Serevent, because of relaxed prescribing rules which see Special Authorities removed. More >>
Obesity epidemic fuels worrying diabetes trends
Tuesday, 4 July 2006, 9:29 am | PHARMAC
The obesity epidemic is behind a disturbing rise in diabetes in New Zealand, with this age-related disease now increasingly hitting teenagers. More >>
Antibiotics secured for influenza pandemic
Monday, 26 June 2006, 2:52 pm | PHARMAC
New Zealanders will have access to a secure supply of antibiotics for use during an influenza pandemic. More >>
Once-a-day insulin subsidised for NZ patients
Monday, 26 June 2006, 9:43 am | PHARMAC
A type of insulin for people with diabetes that requires only one injection a day will be funded from 1 July, PHARMAC announced today. More >>
10 days to 17 seconds at the touch of a button
Wednesday, 21 June 2006, 9:53 am | PHARMAC
Medicines approvals that had taken 10 days can now occur in as little as 17 seconds, thanks to a new electronic system available for doctors. More >>
Herceptin given full consideration by PTAC
Thursday, 25 May 2006, 3:41 pm | PHARMAC
The Pharmacology and Therapeutics Advisory Committee today considered further clinical evidence on the use of trastuzumab (Herceptin) for early breast cancer. More >>
More choice for heart risk patients
Thursday, 11 May 2006, 2:25 pm | PHARMAC
Chief Executive Wayne McNee says the listing of Cartia provides further choice for patients wanting to reduce their chance of having a heart attack or stroke. Cartia is the second brand of low dose aspirin to be subsidised following the decision to ... More >>
Funding moves take on hepatitis B
Thursday, 6 April 2006, 11:58 am | PHARMAC
New moves to tackle the leading cause of liver cancer have been announced by drug-funding agency PHARMAC. More >>
PHARMAC agrees funding for brain tumour treatment
Monday, 3 April 2006, 3:24 pm | PHARMAC
A new treatment for people with an aggressive form of brain tumour is to become fully subsidised from 1 May 2006. More >>
PHARMAC agrees funding for brain tumour treatment
Monday, 3 April 2006, 2:09 pm | PHARMAC
A new treatment for people with an aggressive form of brain tumour is to become fully subsidised from 1 May 2006. More >>
PHARMAC welcomes Medsafe approval of Herceptin
Thursday, 23 March 2006, 2:33 pm | PHARMAC
Medsafe’s decision to provisionally approve the wider use of the breast cancer drug Herceptin is welcomed and will enable PHARMAC to progress its assessment further, says PHARMAC spokeswoman Dr Dilky Rasiah. More >>
PHARMAC releases Australia vs NZ comparison
Monday, 20 March 2006, 3:52 pm | PHARMAC
PHARMAC has released its data on comparisons between medicines subsidised in New Zealand and Australia. More >>
PHARMAC, Schering-Plough reach agreement
Thursday, 2 March 2006, 2:15 pm | PHARMAC
PHARMAC and Schering-Plough have reached a provisional agreement for funding of the brain tumour treatment temozolomide (Temodal). More >>
